The evaluation of a patient with a history suggestive of coronary artery disease is familiar to any internist. After a careful history and physical examination, the internist often turns to exercise testing to provide further diagnostic information. If the patient has an abnormal test result, the physician is faced with deciding whether to refer the patient for more invasive testing and therapy. There should be specific reasons to send a patient with stable angina to cardiac catheterization. Cardiac catheterization is a procedure that provides anatomic rather than functional information. Thus, the major reason to catheterize a patient is to assess whether the patient has the appropriate anatomy for invasive therapy, including coronary artery bypass surgery and percutaneous transluminal coronary angioplasty. In deciding which patient to refer for catheterization, the internist should evaluate whether the patient has a higher risk of mortality from the invasive procedures than from medical management. If the answer to this question is no, then the catheterization can lead to improved survival. Remember that this relates only to the issue of quantity of life and not quality of life.
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The decision-making process becomes more difficult when catheterization is looked at as a tool to decide whether angioplasty is an appropriate course of therapy. Unfortunately, there are little comparative data regarding angioplasty as an alternative to medical therapy. Coronary artery bypass surgery is the current standard of care for patients with three-vessel or left main disease, the only coronary anatomy that has been associated with improved survival after revascularization compared with medical therapy. ( Table 1) . Variables found to be independently associated with time to cardiovascular death were weighted, according to their power, to create an equation that calculates a numeric score. Annual mortality for 4 years of follow-up was determined in each population. The derived equations allow stratification of patients into low-, moderate-, and highrisk groups (Table 2) . Additionally, polynomial equations were calculated from the plots of mortality vs prognostic score that allows for individualized calculation of estimated mortality for a specific score (Table 3) . Such a protocol allowed the investigators to assess more accurately which patients warranted referral for cardiac catheterization; namely, those patients whose risk of mortality from coronary artery disease was higher than that from coronary artery bypass surgery. The VA study additionally provided further evidence of overuse of invasive cardiac procedures, even in a "non-fee for service" setting. Of the 588 patients selected for cardiac catheterization, 53% had a projected 4-year cardiovascular mortality of less than 2%.7 Of those selected for bypass surgery, 35% had a 4-year cardiovascular mortality of less than 2%. The Parsonnet scoring system, which estimates operative mortality from case-mix data, yields a minimum 2% mortality from coronary artery bypass surgery, even in patients of the lowest risk profile.9 Therefore, these patients would usually do better with medical management and do not require invasive procedures.
It appears that physicians have an exaggerated perception of the risk of ischemia in patients with stable coronary artery disease. Therefore, the studies concluded that the use of such equations permits a better understanding of the risk of ischemia and helps internists to restrict cardiac catheterization and by- Is it reasonable to assume that the equ structed for these two specific study I generate data that are valid for the patib practicing internist? Both studies attemj dress this question through their study though the equations were each gener populations with a relatively high prevale ease, each group reaffirmed their findings evaluating an outpatient population.7'8' tionally, the researchers at the VA analyz population with the Duke score, and four resultant risk stratification was very simi generated by the VA scorell (Fig 1) . This suggests that the scores are applicable to a tient population. Nevertheless, the Duk more applicable to women and nonveteran VA population had no women, and the I has been independently validated. The should be used for veterans and also for pa have a history of congestive heart failure exertional hypotension since the Duke sco consider these indicators.
DEFENSE OF NATURAL HISTORY STU]
Critics of this approach to evaluation patients with coronary artery disease woul the ability of the Duke and VA studies tc curately outcome. It is true that attempts t( the natural history of coronary artery c plagued by the necessity of intervention i presents with an unstable clinical picture words, if a patient were to present with ui gina, it would not be medicolegally feasible to allow the patient to continue without treatment to observe outcome, given high clinical suspicion of an adverse result. Therefore, the sickest patients may be removed from the data analysis and lessen the ability of certain variables to predict outcome. On nstable anjudiciously use invasive cardiac procedures.
ESTIMATED PROGNOSIS
The age expected annual mortality from any cause is 5.4% (National Center for Health Statistics, 1990 ). The VA score (METs, CHF, SBP rise, and ST depression) estimates an annual cardiovascular mortality of 4.4% (not greater than two times the age expected mortality). The Duke Score (METs, ST depression, and treadmill angina) estimates an annual cardiovascular mortality of 3.7% (not greater than two times the age expected mortality). The estimated operative mortalities for bypass surgery are 16% (Parsonnet, 1989) To use the equations to help decide which patients to refer for catheterization, the internist must calculate the mortality risk from coronary bypass surgery for each patient as well as the Duke or VA score. Risk of bypass is highly dependent on patient profile.9
While this process is straightforward, the internist may have concerns about the cost in time needed to calculate risks.
At the PAVAMC, we have developed a computerized expert system called EXTRA (Exercise Test Reporting Aide) that has simplified the process of generating risk profiles. The internist enters pertinent patient information into a computer, including age, race, medications, cardiac history, risk factors, ECG data, and results of the exercise treadmill test. The computer then analyzes the data and at the bottom of the printout calculates both the VA and Duke scores, as well as the age-expected annual mortality from any cause, and the estimated operative mortality for bypass surgery.9'20 (Fig 2) . The immediately printed report, therefore, quickly provides the data that the internist needs to assess the need for invasive cardiac procedures.
FOLLOW-UP OF LOW-RISK PATIENTS
While the VA and Duke equations are based on 4-year survival data for patients in a given risk group, coronary artery disease is a progressive disease, and a patient may change risk group after this time. How should the low-risk patients that are not referred for catheterization be managed?
Prevention
The first approach for the internist is to promote prevention of progressive disease. Recent reduced exercise tolerance, or unstable angina, it is reasonable to assume that the calculated risk will have changed. Therefore, such patients should undergo repeated exercise testing with repeated risk calculation. If the patient is still at a lower risk of cardiac death than risk of operative mortality, the patient should continue to be medically managed.
In summary, current medical practice has taken a very aggressive approach to managing coronary artery disease in terms of both diagnosis and therapy. The number of invasive cardiac procedures performed is increasing, despite decreasing cardiac mortality. Given that this aggressive approach has now become the "standard of care," it is difficult for practitioners to decide against these invasive procedures. Additionally, this aggressive approach fosters an exaggerated notion of the risk of ischemia. Therefore, invasive cardiac procedures are often performed in low-risk patients whose disease severity does not warrant such intervention.
Due to overwhelming public concern over the expense of medical services, rationing of health-care dollars is an increasing priority. Inherent to the process of rationing is the fact that money spent for one patient is de facto being "taken away" from another. Currently, money that could be channeled into AIDS or used to vaccinate children is being spent on unnecessary cardiac procedures. There exist ways, however, to allow the internist to decide which patients require invasive measures using noninvasive parameters. After a history, physical examination, and a treadmill test, the Duke and VA scoring systems allow internists to provide information regarding the patient's status and to help make recommendations for optimal management. With advances in computerized data gathering, these scoring systems will become progressively easier to use. The internist will thus be able to rapidly determine both a diagnostic and therapeutic plan and provide the patient with prognostic information. Ultimately, this will lead to a more cost-effective and appropriate use of invasive cardiac procedures.
